These measurements are not really quantitative, and thus direct comparison with our model is not possible, but one could perhaps speculate whether during cancer progression parameters of the NF-κB system change in such a way as to promote anomalous limit cycle oscillations in a low-dose tissue micro-environment. Here, NFKB1 is linked to cancer.